{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:03:47Z","timestamp":1789967027329,"version":"4.0.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human papillomaviruses (HPVs) utilize specifically modified proteoglycans (PGs) within the basement membrane as attachment factors prior to cell entry and infection. Similarly modified PGs are also found on cancer cells, which enables HPV with tumor-selective binding properties and highlights the potential development of HPV capsid-based anti-cancer therapies. In this study, we sought to investigate cancer-specific gene signatures and genetic factors that give rise to selective binding by HPV capsids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using belzupacap sarotalocan (bel-sar; AU-011), an HPV virus-like drug conjugate (HPV-VDC) currently in clinical trials, we performed a cell binding screen using 115 cancer cell lines from which we performed gene expressions analysis. We developed drug resistant lines to investigate the developmental factors involved in tumor targeting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified a strong association between drug binding and pathways involved in TGF-\u03b2-induced epithelial to mesenchymal transition (EMT). Furthermore, dose escalation treatments leading to selection of bel-sar resistant HeLa cells resulted in a marked reduction in TGF-\u03b2 signaling and reversal of EMT, which was associated with a reduction in the synthesis and expression of heparan- and chondroitin sulfate proteoglycans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, these data suggest that bel-sar binding is strongly dependent on the differential expression and modification of PGs that occurs during the EMT process. As many cancers undergo EMT during progression and invasion, these data provide mechanistic insights underlying the tumor-selective binding ability of HPV-VDCs. (200 words).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1918692","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:29:10Z","timestamp":1789964950000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["TGF-\u03b2-induced epithelial to mesenchymal transition drives proteoglycan binding specificity of HPV-based drug conjugates for cancer cells"],"prefix":"10.3389","volume":"16","author":[{"given":"Nathan R.","family":"Fons","sequence":"first","affiliation":[{"name":"Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health","place":["Bethesda, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda C.","family":"Kines","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health","place":["Bethesda, MD, United States"]},{"name":"Aura Biosciences","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastoo","family":"Azadi","sequence":"additional","affiliation":[{"name":"Complex Carbohydrate Research Center, University of Georgia","place":["Athens, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Archer-Hartmann","sequence":"additional","affiliation":[{"name":"Complex Carbohydrate Research Center, University of Georgia","place":["Athens, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Lowy","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health","place":["Bethesda, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"de los Pinos","sequence":"additional","affiliation":[{"name":"Aura Biosciences","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Schiller","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health","place":["Bethesda, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2010.04.004","article-title":"Current understanding of the mechanism of HPV infection","volume":"118","author":"Schiller","year":"2010","journal-title":"Gynecologic Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mrrev.2016.09.004","article-title":"HPV entry into cells","volume":"772","author":"Aksoy","year":"2017","journal-title":"Mutat Res Rev Mutat Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0908502106","article-title":"The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding","volume":"106","author":"Kines","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.52843\/cassyni.skbp7z","article-title":"Chondroitin sulfate proteoglycans are de facto cellular receptors for human papillomavirus 16 under high serum conditions","volume":"96","author":"Fons","year":"2022","journal-title":"J Virol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29823","article-title":"Human papillomavirus capsids preferentially bind and infect tumor cells","volume":"138","author":"Kines","year":"2016","journal-title":"Int J Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01631-08","article-title":"Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids","volume":"82","author":"Day","year":"2008","journal-title":"J Virol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-17-0953","article-title":"An infrared dye\u2013conjugated virus-like particle for the treatment of primary uveal melanoma","volume":"17","author":"Kines","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/v14081656","article-title":"Harnessing human papillomavirus' natural tropism to target tumors","volume":"14","author":"Kines","year":"2022","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00749","article-title":"The role of proteoglycans in cancer metastasis and circulating tumor cell analysis","volume":"8","author":"Ahrens","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-060713-035314","article-title":"Demystifying heparan sulfate\u2013protein interactions","volume":"83","author":"Xu","year":"2014","journal-title":"Annu Rev Biochem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2010.01236.x","article-title":"Proteoglycans in cancer biology, tumour microenvironment and angiogenesis","volume":"15","author":"Iozzo","year":"2011","journal-title":"J Cell Mol Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186588","article-title":"Heparan sulfate proteoglycan signaling in tumor microenvironment","volume":"21","author":"De Pasquale","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-018-0086-z","article-title":"The GAGOme: a cell-based library of displayed glycosaminoglycans","volume":"15","author":"Chen","year":"2018","journal-title":"Nat Methods"},{"key":"B14","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1369\/0022155412464972","article-title":"Heparan sulfate biosynthesis: regulation and variability","volume":"60","author":"Kreuger","year":"2012","journal-title":"J Histochem Cytochem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21175983","article-title":"Roles of proteoglycans and glycosaminoglycans in cancer development and progression","volume":"21","author":"Wei","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109822","article-title":"Cell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer","volume":"77","author":"Hassan","year":"2021","journal-title":"Cell Signal"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215328","article-title":"Proteoglycans determine the dynamic landscape of EMT and cancer cell stemness","volume":"14","author":"Karagiorgou","year":"2022","journal-title":"Cancers"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial\u2013mesenchymal transition","volume":"21","author":"Yang","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112767","article-title":"TGF-\u03b2-mediated epithelial-mesenchymal transition and cancer metastasis","volume":"20","author":"Hao","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404208","article-title":"Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients","volume":"6","author":"Tan","year":"2014","journal-title":"EMBO Mol Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2009.05.001","article-title":"Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion","volume":"21","author":"Mythreye","year":"2009","journal-title":"Cell Signalling"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.mcr-16-0313","article-title":"A transcriptional program for detecting TGF\u03b2-induced EMT in cancer","volume":"15","author":"Foroutan","year":"2017","journal-title":"Mol Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2009.5","article-title":"TGF-\u03b2-induced epithelial to mesenchymal transition","volume":"19","author":"Xu","year":"2009","journal-title":"Cell Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2008.302","article-title":"Signaling cross-talk between TGF-\u03b2\/BMP and other pathways","volume":"19","author":"Guo","year":"2009","journal-title":"Cell Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6010007","article-title":"Stromal modulators of TGF-\u03b2 in cancer","volume":"6","author":"Costanza","year":"2017","journal-title":"J Clin Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m703341200","article-title":"Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-\u03b2 (TGF-\u03b2) by modulating assembly of latent TGF-\u03b2-binding protein-1","volume":"282","author":"Chen","year":"2007","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s12079-009-0066-2","article-title":"The matricellular functions of small leucine-rich proteoglycans (SLRPs)","volume":"3","author":"Merline","year":"2009","journal-title":"J Cell Commun Signaling"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01479","article-title":"Integrative transcriptomic analysis reveals a multiphasic epithelial\u2013mesenchymal spectrum in cancer and non-tumorigenic cells","volume":"9","author":"Panchy","year":"2020","journal-title":"Front Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/s1097-2765(00)80061-1","article-title":"Human Smad3 and Smad4 are sequence-specific transcription activators","volume":"1","author":"Zawel","year":"1998","journal-title":"Mol Cell"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-2835-5_14","article-title":"Isolation and compositional analysis of glycosaminoglycans","volume-title":"Chemokine-Glycosaminoglycan Interactions: Methods and Protocols","author":"Archer-Hartmann","year":"2023"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10719-012-9427-9","article-title":"The proteoglycan repertoire of lymphoid cells","volume":"29","author":"Fadnes","year":"2012","journal-title":"Glycoconjugate J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"B37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2013.0466","article-title":"The role of TGF\u03b2 signaling in wound epithelialization","volume":"3","author":"Ramirez","year":"2013","journal-title":"Adv Wound Care"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2019.04.009","article-title":"Extracellular events impacting human papillomavirus infections: epithelial wounding to cell signaling involved in virus entry","volume":"7","author":"Ozbun","year":"2019","journal-title":"Papillomavirus Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12580445","article-title":"Transforming growth factor-beta: selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis","volume":"89","author":"Falanga","year":"1987","journal-title":"J Invest Dermatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3109\/01902149009068816","article-title":"Effect of transforming growth factor beta on synthesis of glycosaminoglycans by human lung fibroblasts","volume":"16","author":"Dubaybo","year":"1990","journal-title":"Exp Lung Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013002","article-title":"Glycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems","volume":"5","author":"Maupin","year":"2010","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101508","article-title":"The aberrant cancer metabolic gene carbohydrate sulfotransferase 11 promotes non-small cell lung cancer cell metastasis via dysregulation of ceruloplasmin and intracellular iron balance","volume":"25","author":"Chang","year":"2022","journal-title":"Transl Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.109.5.2509","article-title":"Transforming growth factor (type beta) promotes the addition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia","volume":"109","author":"Rapraeger","year":"1989","journal-title":"J Cell Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022137","article-title":"Signaling cross talk between TGF-\u03b2\/Smad and other signaling pathways","volume":"9","author":"Luo","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2020.1838034","article-title":"Heparan sulfate proteoglycans as targets for cancer therapy: a review","volume":"21","author":"Onyeisi","year":"2020","journal-title":"Cancer Biol Ther"},{"key":"B47","doi-asserted-by":"publisher","first-page":"7553","DOI":"10.1038\/s41467-024-51781-0","article-title":"Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate","volume":"15","author":"Vidal-Calvo","year":"2024","journal-title":"Nat Commun"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m110.160184","article-title":"Structural basis of oligosaccharide receptor recognition by human papillomavirus","volume":"286","author":"Dasgupta","year":"2011","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.9.5810","article-title":"The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes","volume":"274","author":"Joyce","year":"1999","journal-title":"J Biol Chem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.09.003","article-title":"Targeting human cancer by a glycosaminoglycan binding malaria protein","volume":"28","author":"Salanti","year":"2015","journal-title":"Cancer Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"101391","DOI":"10.1016\/j.jbc.2021.101391","article-title":"The specificity of the malarial VAR2CSA protein for chondroitin sulfate depends on 4-O-sulfation and ligand accessibility","volume":"297","author":"Spliid","year":"2021","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.3390\/cancers12082154","article-title":"EMT-inducing transcription factors, drivers of melanoma phenotype switching, and resistance to treatment","volume":"12","author":"Tang","year":"2020","journal-title":"Cancers"},{"key":"B53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/dvdy.24678","article-title":"Epithelial-mesenchymal transition and cancer stem cells: At the crossroads of differentiation and dedifferentiation","volume":"248","author":"Wang","year":"2019","journal-title":"Dev Dyn"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1918692\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:29:12Z","timestamp":1789964952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1918692\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":53,"alternative-id":["10.3389\/fonc.2026.1918692"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1918692","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"1918692"}}